Neumora Therapeutics, Inc. Common Stock (NMRA) has a market capitalization of $375M and trades at $2.06. The 52-week range is 0.611-3.65.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1.4, Earnings Per Share (EPS) of $-1.45.
The stock has a beta of 3.12, operates in the Healthcare sector.
